Literature DB >> 7600835

Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine.

J A Kline1, E Leonova, R M Raymond.   

Abstract

OBJECTIVE: Myocardial depression from verapamil toxicity may result from alterations in carbohydrate metabolism as well as calcium-channel antagonism. We hypothesized that pharmacologic doses of insulin may be effective in reversing both of these deficits.
DESIGN: Randomized, controlled, prospective study.
SETTING: Laboratory of an urban hospital.
SUBJECTS: Thirty mongrel dogs.
INTERVENTIONS: Thirty mongrel canines were anesthetized with alpha-chloralose. Toxicity was induced by the administration of 0.1 mg/kg/min iv of verapamil, until there was a 50% reduction in mean arterial pressure, for 30 mins (titration), followed by a continuous verapamil infusion of 1 mg/kg/hr. Animals (n = 6 per group) were randomized to the control group (saline only) or to one of four treatment protocols: a) calcium chloride (20 mg/kg), then 0.6 mg/kg/hr; b) hyperinsulinemia-euglycemia (4.0 U/min of recombinant insulin, with arterial glucose concentration clamped to +/- 10 mg/dL [+/- 0.5 mmol/L] of the basal value); c) epinephrine, with a starting rate of 1.0 microgram/kg/min, titrated to maintain left ventricular pressure at basal values; or d) glucagon, a 0.2-mg/kg bolus, followed by a 150-microgram/kg/hr infusion. Animals were monitored until death or 240 mins; infusate volumes were held constant for all groups.
MEASUREMENTS AND MAIN RESULTS: During verapamil titration, the myocardial respiratory quotient increased from 0.84 +/- 0.05 to 1.07 +/- 0.11 (p < .05, paired t-test) and myocardial glucose uptake doubled, despite a reduction in cardiac work (p < .05, paired t-test). Net myocardial lactate uptake also increased significantly, excluding myocardial ischemia. In controls, this trend continued, indicating preferential carbohydrate metabolism during untreated verapamil toxicity. Despite hyperglycemia, the plasma insulin concentration was not significantly different in controls (basal value 11 +/- 2 vs. 39 +/- 21 microU/mL at 30 mins). Hyperinsulinemia-euglycemia increased both myocardial glucose and lactate uptake five-fold, and significantly increased the ratio of myocardial oxygen delivery/work, along with superior improvements in maximal left ventricular elastance at end systole compared with other treatments (p < .05 vs. other treatments, contrast analysis).
CONCLUSIONS: Verapamil toxicity renders the heart dependent on carbohydrate metabolism. Inasmuch as the positive inotropic effects of all treatments were coincident with increased indices of myocardial carbohydrate uptake, adequate treatment of verapamil toxicity appeared to require maximal myocardial carbohydrate utilization. Hyperinsulinemia-euglycemia allows larger increases in myocardial carbohydrate metabolism and myocardial contractility than calcium chloride, epinephrine, or glucagon, resulting in improved survival rates during severe verapamil toxicity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600835     DOI: 10.1097/00003246-199507000-00016

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

1.  Life-threatening calcium channel blocker overdose and its management.

Authors:  Imran Rizvi; Ajaz Ahmad; Ankush Gupta; Shamsuz Zaman
Journal:  BMJ Case Rep       Date:  2012-05-30

Review 2.  Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies.

Authors:  Andis Graudins; Hwee Min Lee; Dino Druda
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

3.  Case files of the medical toxicology fellowship training program at the New York city poison control center: hypotensive death--therapeutic complication or suicide?

Authors:  S Eliza Halcomb; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2006-06

Review 4.  Intravenous fat emulsion: a potential novel antidote.

Authors:  Danielle E Turner-Lawrence; William Kerns Ii
Journal:  J Med Toxicol       Date:  2008-06

5.  Management of a mixed overdose of calcium channel blockers, β-blockers and statins.

Authors:  Reena Thakrar; Rob Shulman; Geoff Bellingan; Mervyn Singer
Journal:  BMJ Case Rep       Date:  2014-06-06

Review 6.  Management of calcium channel antagonist overdose.

Authors:  Steven D Salhanick; Michael W Shannon
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

7.  A fatal case of iatrogenic hypercalcemia after calcium channel blocker overdose.

Authors:  Michael T Sim; Frazier T Stevenson
Journal:  J Med Toxicol       Date:  2008-03

8.  Insulin-dependent rescue from cardiogenic shock is not mediated by phospholamban phosphorylation.

Authors:  Naa-Adjeley Ablorh; Florentin Nitu; Kristin Engebretsen; David D Thomas; Joel S Holger
Journal:  Clin Toxicol (Phila)       Date:  2009-04       Impact factor: 4.467

9.  Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study.

Authors:  Shaun L Greene; Indika Gawarammana; David M Wood; Alison L Jones; Paul I Dargan
Journal:  Intensive Care Med       Date:  2007-07-11       Impact factor: 17.440

10.  Hyperinsulinemia euglycemia therapy for calcium channel blocker overdose: a case report.

Authors:  Anushree Agarwal; Siegfried W Yu; Abdul Rehman; Joseph Q Henkle
Journal:  Tex Heart Inst J       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.